Navigation Links
BELLUS Health reports results for first quarter of fiscal 2009
Date:5/6/2009

LAVAL, QC, May 6 /PRNewswire-FirstCall/ - BELLUS Health Inc. ("BELLUS Health" or the "Company") (TSX: BLU) reported results for the first quarter ended March 31, 2009. The Company reported a net loss of $9,907,000 ($0.20 per share) for the quarter, compared to $13,042,000 ($0.27 per share) for the same period the previous year. The decrease in the net loss is mainly due to a reduction in research and development (R&D) expenses, before research tax credits and grants, which amounted to $3,610,000 for the current quarter, compared to $8,780,000 for the same period the previous year. The decrease is mainly attributable to a reduction in the research and development of tramiprosate (ALZHEMED(TM); homotaurine) for the treatment of Alzheimer's disease following the Company's decision in November 2007 to terminate the tramiprosate (ALZHEMED(TM)) pharmaceutical drug development program. The Company is also developing NC-503 (eprodisate) for the treatment of Type II diabetes and certain features of metabolic syndrome.

As at March 31, 2009, the Company had available cash, cash equivalents and marketable securities of $3,187,000, compared to $10,595,000 at December 31, 2008. The decrease is primarily due to funds used in operating activities.

On April 16, after the end of the first quarter of 2009, the Company announced the completion of the first tranche of its previously announced $20.5 million CAD convertible notes (see Liquidity and capital resources section for further details). BELLUS Health received gross proceeds of $10 million CAD for the issuance of new convertible notes. A second tranche of $10.5 million CAD is expected to be funded by June 2009. In March 2009, the Company announced a reduction in the workforce and other related measures which are expected to result in annual savings of approximately $3.5 million CAD, and the restructuring of the lease of the Company's main premises and the 2006 and 2007 convertible notes, which are expect
'/>"/>

SOURCE BELLUS HEALTH INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related medicine news :

1. BELLUS announces Chief Financial Officer to depart effective May 22, 2009
2. BELLUS Health inc. announces completion of first tranche of financing
3. BELLUS Health reports results for the fourth quarter of 2008
4. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BELLUS Health Inc.
5. BELLUS Health announces formal notice to voluntarily delist from NASDAQ
6. BELLUS Health is Preparing to Voluntarily Delist from the NASDAQ Capital Market
7. BELLUS Health Announces Stock Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market
8. BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update
9. BELLUS Health to present at the Rodman and Renshaw 10th Annual Healthcare Conference
10. BELLUS Health provides update on activities
11. BELLUS Health announces closing of Innodia acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 24, 2014) If past experience is anything ... are about to get a lot more recognition for ... on the books allowing NPs to provide primary care ... care and better relationships with physicians and administrators, compared ... from Columbia University School of Nursing, published in ...
(Date:7/23/2014)... 2014 Celebrating a decade of philanthropy ... announced the awarding of $1,070,000 in grants to 20 ... recognition of the Foundation’s 1,000th grant. , “The Horizon ... tradition of supporting community-based organizations that are working to ... in the Garden State,” said Robert A. Marino, Horizon ...
(Date:7/23/2014)... body of research suggesting a safe and effective ... breast cancer, with fewer detrimental side effects and ... The study will be published in final format ... and Endocrinology . , Breast cancer is the ... United States. Approximately 70% of breast cancers are ...
(Date:7/23/2014)... 23, 2014 Global Cardio Care, Inc., ... External Counterpulsation (EECP), is celebrating the 100th birthday ... at the health center. , Weber has been ... receiving ongoing EECP therapy since 1999, he no longer ... CEO of Global Cardio Care, introduced the Sara ...
(Date:7/23/2014)... The voice on the recording was low and calm as ... was infected with the human immunodeficiency virus (HIV) that causes AIDS: ... you know I was on the floor flat on my face ... when the recording ended less than 10 minutes later. “Don’t feel ... because it is just God setting you up for something greater,” ...
Breaking Medicine News(10 mins):Health News:New York law offers nurses more recognition, responsibility 2Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 2Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 3Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 4Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 5Health News:Hormones after breast cancer: Not fuel for the fire after all? 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 4Health News:Hormones after breast cancer: Not fuel for the fire after all? 5Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 3
... to begin studies about a vaccine that makes a person ... the name of the vaccine is undergoing trials, and if ... 2 years time. ,The vaccine targets the pleasure ... results in obliterating the urge to smoke. The vaccine is ...
... injury by maintaining Adenosine Tri Phosphate (ATP) levels in ... an antibiotic (used to trigger organ survival in transplant ... heart tissue damage after an acute heart attack might ... issue of the Journal of Molecular and Cellular Cardiology, ...
... at Stanford’s School of Medicine and Lucile Packard Children’s ... cause for mental retardation//in Down syndrome, in a gene ... normally, affecting attention, and memory. ,The researchers ... have identified a gene that, if over-produced, could cause ...
... Service suggests that reducing the dose of radiation for patients ... It is estimated that cancers caused by X-rays kill 780 ... said that many new devices that use X-rays to push ... sufficiently tested and their efficacy and safety remains unknown. ...
... For the first time in China, doctors have successfully ... a taboo on taking organs from people whom Chinese ... the first transplant with a heart extracted from a ... ethical significance," Chen Zhonghua, director of Institute of Organ ...
... cause diabetes in children and young adults, say scientists who ... people //with type 1 diabetes in Britain's Yorkshire county. ... any insulin to control levels of sugar in the blood, ... ,The researchers led by Dr Richard McNally from Leeds ...
Cached Medicine News:Health News:Antibiotic Proved Protective against Heart Tissue Damage and Cell Death – Research Find 2Health News:Stanford Researchers Identify A Gene Causing Downs Syndrome 2
(Date:7/23/2014)...  The management team at Columbia Laboratories, Inc. ... conference call on July 31, 2014, to discuss ... 30, 2014.  The call details are as follows:Date: ... EDTDial-in numbers: , Toll free: (877) 870-4263 (U.S.), ... archive): , www.columbialabs.com , under ,Investor, or ...
(Date:7/23/2014)... ORANGE, Calif. , July 23, 2014 ... will gather in Las Vegas ... event. Spearheaded by educator, author, forward thinker and private ... to bring experts together to candidly discuss clinical and ... two day event is a unique opportunity to welcome ...
(Date:7/23/2014)... , July 23, 2014  Silk Road ... the transcarotid treatment of intra- and extra-cranial cerebrovascular ... P. Wallace to the position of Chief ... lead the company,s Research and Development efforts across ... Prior to joining Silk Road ...
Breaking Medicine Technology:Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 22014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 3
... Analyzes the Effectiveness and Safety of Statin Use for Those Who Need It , ... Recommendations for Choosing a ,Best Buy, Statin and Strategies for ... YONKERS, N.Y. , June 29 ... ) caution that the benefits of statin use by children and some women may ...
... Initiative Launched on Biosafety , , ... WASHINGTON , June 29 Remember chemistry sets, ham radio, amateur ... 2,000 people from around the world belong to the Do-It-Yourself Biology (DIYbio) community, ... bio-monitoring, to new treatments for diseases. , ...
Cached Medicine Technology:Consumer Reports Health Questions Use of Statins By Children and Some Women 2Consumer Reports Health Questions Use of Statins By Children and Some Women 3Consumer Reports Health Questions Use of Statins By Children and Some Women 4Consumer Reports Health Questions Use of Statins By Children and Some Women 5Consumer Reports Health Questions Use of Statins By Children and Some Women 6Consumer Reports Health Questions Use of Statins By Children and Some Women 7Responsible Science for Do-It-Yourself Biologists 2
... The Self-Cath family of ... patients a variety of ... Each catheter is ... grade PVC and has ...
... The Self-Cath family of ... patients a variety of ... Each catheter is ... grade PVC and has ...
IMMCO ANA Elisa meets the guidelines for the laboratory diagnosis and monitoring of systemic autoimmune rheumatic diseases intended for the use of clinical pathologists and laboratory physicians....
... is engineered to distribute contact pressure evenly over ... back, to maximize stability and patient comfort. ... readily conformable to patient anatomy, to provide a ... wool liner is standard on both units, as ...
Medicine Products: